Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

November 29, 2015 2:35 PM ET

Life Sciences Tools and Services

Company Overview of Oncoceutics, Inc.

Executive Profile

Martin Stogniew Ph.D.

Chief Development Officer, Oncoceutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 1 Board Members in 1 different organizations across 6 different industries.

See Board Relationships


Dr. Martin Stogniew, Ph.D. serves as the Chief Development Officer at Oncoceutics, Inc. Dr. Stogniew served as Vice President of Pharmaceutical Sciences at Ceptaris Therapeutics Inc. since July 2011. Dr. Stogniew served as Chief Technology Officer and Executive Vice President of Prestwick Pharmaceuticals, Inc. since August 30, 2007. Dr. Stogniew served as an Executive Vice President of Development at Azelon Pharmaceuticals, Inc. (Zelos Therapeutics Inc.) since May 2006. ...

Corporate Headquarters

1214 Research Boulevard
Hummelstown, Pennsylvania 17036

United States

Phone: 917-327-6423
Fax: --

Board Members Memberships



University of Maryland
University of Maryland

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Oncoceutics, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at